Mycronic AB (publ)
MICLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.41 | -0.66 | 0.21 | 4.07 |
| FCF Yield | 0.00% | 1.28% | 1.36% | 3.35% |
| EV / EBITDA | 91.98 | 55.00 | 18.53 | 31.27 |
| Quality | ||||
| ROIC | 3.58% | 5.85% | 8.16% | 6.18% |
| Gross Margin | 46.34% | 53.39% | 61.16% | 48.76% |
| Cash Conversion Ratio | 1.44 | 0.96 | 0.31 | 1.21 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.19% | 15.85% | 13.00% | 11.30% |
| Free Cash Flow Growth | -100.00% | 76.76% | -63.26% | 763.16% |
| Safety | ||||
| Net Debt / EBITDA | -4.76 | -3.10 | -3.44 | -5.21 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.42 | 0.45 | 0.40 | 0.51 |
| Cash Conversion Cycle | 259.30 | 233.56 | 247.73 | 202.45 |